
New Alzheimer’s treatment
Developed by Eli Lilly, Kisunla is the first medicine approved in Australia that targets the underlying cause of Alzheimer’s by clearing the amyloid plaques that disrupt brain function. It is the first new Alzheimer’s treatment registered in Australi...




